Global Information
회사소개 | 문의 | 비교리스트

암 지지요법 약제 : 세계 시장 전망(2018-2027년)

Cancer Supportive Care Drugs - Global Market Outlook (2018-2027)

리서치사 Stratistics Market Research Consulting
발행일 2020년 05월 상품 코드 939130
페이지 정보 영문 180 Pages
가격
US $ 4,150 ₩ 4,774,000 PDF by E-mail (Single User License)
US $ 5,250 ₩ 6,040,000 PDF by E-mail (2-5 User License)
US $ 6,350 ₩ 7,305,000 PDF by E-mail (Site License)
US $ 7,500 ₩ 8,628,000 PDF by E-mail (Global Site License)


암 지지요법 약제 : 세계 시장 전망(2018-2027년) Cancer Supportive Care Drugs - Global Market Outlook (2018-2027)
발행일 : 2020년 05월 페이지 정보 : 영문 180 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 암 지지요법 약제 시장은 2018년에 211억 달러를 기록했습니다. 이 시장은 예측 기간 중 3%의 CAGR로 성장할 전망이며, 2027년에는 275억 3,000만 달러에 달할 것으로 예측되고 있습니다. 시장 성장을 촉진하는 주요 요인에는 헬스케어비의 증가, 진보 치료의 이용 가능성, 암의 발생 증가 등을 들 수 있습니다. 그러나 엄격한 규제 프로세스는 시장 성장을 방해하는 요인입니다.

세계의 암 지지요법 약제 시장에 대해 조사했으며, 시장 기회 및 동향, 성장 및 억제요인, 암 유형·약제 클래스·유통 채널·지역별 시장 분석, 경쟁 구도, 주요 기업의 개요 등의 정보를 정리하여 전해드립니다.

목차

제1장 개요

제2장 서론

제3장 시장 동향 분석

  • 서론
  • 성장요인
  • 억제요인
  • 시장 기회
  • 위협
  • 용도 분석
  • 신흥 시장
  • 신종 코로나바이러스 감염증의 영향

제4장 Porter의 산업 분석

제5장 세계 시장 : 암 유형별

  • 서론
  • 간암
  • 폐암
  • 백혈병
  • 난소암
  • 유방암
  • 흑색종
  • 방광암
  • 전립선암

제6장 세계 시장 : 약물 클래스별

  • 서론
  • 비스테로이드성항염증약(NSAIDs)
  • 항구토제
  • ESA(Erythropoietin-stimulating Agents)
  • 비스포스포네이트
  • 과립구집락자극인자(G-CSF)
  • 오피오이드
  • 국소
  • 기타
    • 호중구감소증
    • 항종양성 항생제

제7장 세계 시장 : 유통 채널별

  • 서론
  • 소매 약국
  • 병원 약국
  • 온라인 약국

제8장 세계 시장 : 용도별

  • 서론
  • 방사선 치료
  • 화학요법

제9장 세계 시장 : 지역별

  • 서론
  • 북미
  • 유럽
  • 아시아태평양
  • 남미
  • 중동·아프리카

제10장 주요 발전

  • 계약, 제휴, 협업, 합병사업
  • 인수합병
  • 신제품 발매
  • 확장
  • 기타 주요 전략

제11장 기업 개요

  • Johnson & Johnson
  • Amgen
  • Novartis
  • Hoffmann La- Roche
  • Baxter International
  • Acacia Pharma
  • Teva Pharmaceuticals Industries
  • Apr Applied Pharma Science Research
  • Fagron Group
  • Kyowa Hakko Kirin
KSA 20.06.12

List of Tables

  • Table 1 Global Cancer Supportive Care Drugs Market Outlook, By Region (2017-2027) ($MN)
  • Table 2 Global Cancer Supportive Care Drugs Market Outlook, By Cancer Type (2017-2027) ($MN)
  • Table 3 Global Cancer Supportive Care Drugs Market Outlook, By Liver Cancer (2017-2027) ($MN)
  • Table 4 Global Cancer Supportive Care Drugs Market Outlook, By Lung Cancer (2017-2027) ($MN)
  • Table 5 Global Cancer Supportive Care Drugs Market Outlook, By Leukemia (2017-2027) ($MN)
  • Table 6 Global Cancer Supportive Care Drugs Market Outlook, By Ovarian Cancer (2017-2027) ($MN)
  • Table 7 Global Cancer Supportive Care Drugs Market Outlook, By Breast Cancer (2017-2027) ($MN)
  • Table 8 Global Cancer Supportive Care Drugs Market Outlook, By Melanoma (2017-2027) ($MN)
  • Table 9 Global Cancer Supportive Care Drugs Market Outlook, By Bladder Cancer (2017-2027) ($MN)
  • Table 10 Global Cancer Supportive Care Drugs Market Outlook, By Prostate Cancer (2017-2027) ($MN)
  • Table 11 Global Cancer Supportive Care Drugs Market Outlook, By Drug Class (2017-2027) ($MN)
  • Table 12 Global Cancer Supportive Care Drugs Market Outlook, By Nonsteroidal Anti-Inflammatory Drugs (NSAIDS) (2017-2027) ($MN)
  • Table 13 Global Cancer Supportive Care Drugs Market Outlook, By Antiemetics (2017-2027) ($MN)
  • Table 14 Global Cancer Supportive Care Drugs Market Outlook, By Erythropoietin-stimulating Agents (ESAS) (2017-2027) ($MN)
  • Table 15 Global Cancer Supportive Care Drugs Market Outlook, By Bisphosphonates (2017-2027) ($MN)
  • Table 16 Global Cancer Supportive Care Drugs Market Outlook, By Granulocyte-Colony Stimulating Factors (G-CSFS) (2017-2027) ($MN)
  • Table 17 Global Cancer Supportive Care Drugs Market Outlook, By Opioids (2017-2027) ($MN)
  • Table 18 Global Cancer Supportive Care Drugs Market Outlook, By Topical (2017-2027) ($MN)
  • Table 19 Global Cancer Supportive Care Drugs Market Outlook, By Other Drug Classes (2017-2027) ($MN)
  • Table 20 Global Cancer Supportive Care Drugs Market Outlook, By Neutropenia (2017-2027) ($MN)
  • Table 21 Global Cancer Supportive Care Drugs Market Outlook, By Antineoplastic Antibiotics (2017-2027) ($MN)
  • Table 22 Global Cancer Supportive Care Drugs Market Outlook, By Distribution Channel (2017-2027) ($MN)
  • Table 23 Global Cancer Supportive Care Drugs Market Outlook, By Retail Pharmacies (2017-2027) ($MN)
  • Table 24 Global Cancer Supportive Care Drugs Market Outlook, By Hospital Pharmacies (2017-2027) ($MN)
  • Table 25 Global Cancer Supportive Care Drugs Market Outlook, By Online Pharmacies (2017-2027) ($MN)
  • Table 26 Global Cancer Supportive Care Drugs Market Outlook, By Application (2017-2027) ($MN)
  • Table 27 Global Cancer Supportive Care Drugs Market Outlook, By Radiation Therapy (2017-2027) ($MN)
  • Table 28 Global Cancer Supportive Care Drugs Market Outlook, By Chemotherapy (2017-2027) ($MN)
  • Table 29 North America Cancer Supportive Care Drugs Market Outlook, By Country (2017-2027) ($MN)
  • Table 30 North America Cancer Supportive Care Drugs Market Outlook, By Cancer Type (2017-2027) ($MN)
  • Table 31 North America Cancer Supportive Care Drugs Market Outlook, By Liver Cancer (2017-2027) ($MN)
  • Table 32 North America Cancer Supportive Care Drugs Market Outlook, By Lung Cancer (2017-2027) ($MN)
  • Table 33 North America Cancer Supportive Care Drugs Market Outlook, By Leukemia (2017-2027) ($MN)
  • Table 34 North America Cancer Supportive Care Drugs Market Outlook, By Ovarian Cancer (2017-2027) ($MN)
  • Table 35 North America Cancer Supportive Care Drugs Market Outlook, By Breast Cancer (2017-2027) ($MN)
  • Table 36 North America Cancer Supportive Care Drugs Market Outlook, By Melanoma (2017-2027) ($MN)
  • Table 37 North America Cancer Supportive Care Drugs Market Outlook, By Bladder Cancer (2017-2027) ($MN)
  • Table 38 North America Cancer Supportive Care Drugs Market Outlook, By Prostate Cancer (2017-2027) ($MN)
  • Table 39 North America Cancer Supportive Care Drugs Market Outlook, By Drug Class (2017-2027) ($MN)
  • Table 40 North America Cancer Supportive Care Drugs Market Outlook, By Nonsteroidal Anti-Inflammatory Drugs (NSAIDS) (2017-2027) ($MN)
  • Table 41 North America Cancer Supportive Care Drugs Market Outlook, By Antiemetics (2017-2027) ($MN)
  • Table 42 North America Cancer Supportive Care Drugs Market Outlook, By Erythropoietin-stimulating Agents (ESAS) (2017-2027) ($MN)
  • Table 43 North America Cancer Supportive Care Drugs Market Outlook, By Bisphosphonates (2017-2027) ($MN)
  • Table 44 North America Cancer Supportive Care Drugs Market Outlook, By Granulocyte-Colony Stimulating Factors (G-CSFS) (2017-2027) ($MN)
  • Table 45 North America Cancer Supportive Care Drugs Market Outlook, By Opioids (2017-2027) ($MN)
  • Table 46 North America Cancer Supportive Care Drugs Market Outlook, By Topical (2017-2027) ($MN)
  • Table 47 North America Cancer Supportive Care Drugs Market Outlook, By Other Drug Classes (2017-2027) ($MN)
  • Table 48 North America Cancer Supportive Care Drugs Market Outlook, By Neutropenia (2017-2027) ($MN)
  • Table 49 North America Cancer Supportive Care Drugs Market Outlook, By Antineoplastic Antibiotics (2017-2027) ($MN)
  • Table 50 North America Cancer Supportive Care Drugs Market Outlook, By Distribution Channel (2017-2027) ($MN)
  • Table 51 North America Cancer Supportive Care Drugs Market Outlook, By Retail Pharmacies (2017-2027) ($MN)
  • Table 52 North America Cancer Supportive Care Drugs Market Outlook, By Hospital Pharmacies (2017-2027) ($MN)
  • Table 53 North America Cancer Supportive Care Drugs Market Outlook, By Online Pharmacies (2017-2027) ($MN)
  • Table 54 North America Cancer Supportive Care Drugs Market Outlook, By Application (2017-2027) ($MN)
  • Table 55 North America Cancer Supportive Care Drugs Market Outlook, By Radiation Therapy (2017-2027) ($MN)
  • Table 56 North America Cancer Supportive Care Drugs Market Outlook, By Chemotherapy (2017-2027) ($MN)
  • Table 57 Europe Cancer Supportive Care Drugs Market Outlook, By Country (2017-2027) ($MN)
  • Table 58 Europe Cancer Supportive Care Drugs Market Outlook, By Cancer Type (2017-2027) ($MN)
  • Table 59 Europe Cancer Supportive Care Drugs Market Outlook, By Liver Cancer (2017-2027) ($MN)
  • Table 60 Europe Cancer Supportive Care Drugs Market Outlook, By Lung Cancer (2017-2027) ($MN)
  • Table 61 Europe Cancer Supportive Care Drugs Market Outlook, By Leukemia (2017-2027) ($MN)
  • Table 62 Europe Cancer Supportive Care Drugs Market Outlook, By Ovarian Cancer (2017-2027) ($MN)
  • Table 63 Europe Cancer Supportive Care Drugs Market Outlook, By Breast Cancer (2017-2027) ($MN)
  • Table 64 Europe Cancer Supportive Care Drugs Market Outlook, By Melanoma (2017-2027) ($MN)
  • Table 65 Europe Cancer Supportive Care Drugs Market Outlook, By Bladder Cancer (2017-2027) ($MN)
  • Table 66 Europe Cancer Supportive Care Drugs Market Outlook, By Prostate Cancer (2017-2027) ($MN)
  • Table 67 Europe Cancer Supportive Care Drugs Market Outlook, By Drug Class (2017-2027) ($MN)
  • Table 68 Europe Cancer Supportive Care Drugs Market Outlook, By Nonsteroidal Anti-Inflammatory Drugs (NSAIDS) (2017-2027) ($MN)
  • Table 69 Europe Cancer Supportive Care Drugs Market Outlook, By Antiemetics (2017-2027) ($MN)
  • Table 70 Europe Cancer Supportive Care Drugs Market Outlook, By Erythropoietin-stimulating Agents (ESAS) (2017-2027) ($MN)
  • Table 71 Europe Cancer Supportive Care Drugs Market Outlook, By Bisphosphonates (2017-2027) ($MN)
  • Table 72 Europe Cancer Supportive Care Drugs Market Outlook, By Granulocyte-Colony Stimulating Factors (G-CSFS) (2017-2027) ($MN)
  • Table 73 Europe Cancer Supportive Care Drugs Market Outlook, By Opioids (2017-2027) ($MN)
  • Table 74 Europe Cancer Supportive Care Drugs Market Outlook, By Topical (2017-2027) ($MN)
  • Table 75 Europe Cancer Supportive Care Drugs Market Outlook, By Other Drug Classes (2017-2027) ($MN)
  • Table 76 Europe Cancer Supportive Care Drugs Market Outlook, By Neutropenia (2017-2027) ($MN)
  • Table 77 Europe Cancer Supportive Care Drugs Market Outlook, By Antineoplastic Antibiotics (2017-2027) ($MN)
  • Table 78 Europe Cancer Supportive Care Drugs Market Outlook, By Distribution Channel (2017-2027) ($MN)
  • Table 79 Europe Cancer Supportive Care Drugs Market Outlook, By Retail Pharmacies (2017-2027) ($MN)
  • Table 80 Europe Cancer Supportive Care Drugs Market Outlook, By Hospital Pharmacies (2017-2027) ($MN)
  • Table 81 Europe Cancer Supportive Care Drugs Market Outlook, By Online Pharmacies (2017-2027) ($MN)
  • Table 82 Europe Cancer Supportive Care Drugs Market Outlook, By Application (2017-2027) ($MN)
  • Table 83 Europe Cancer Supportive Care Drugs Market Outlook, By Radiation Therapy (2017-2027) ($MN)
  • Table 84 Europe Cancer Supportive Care Drugs Market Outlook, By Chemotherapy (2017-2027) ($MN)
  • Table 85 Asia Pacific Cancer Supportive Care Drugs Market Outlook, By Country (2017-2027) ($MN)
  • Table 86 Asia Pacific Cancer Supportive Care Drugs Market Outlook, By Cancer Type (2017-2027) ($MN)
  • Table 87 Asia Pacific Cancer Supportive Care Drugs Market Outlook, By Liver Cancer (2017-2027) ($MN)
  • Table 88 Asia Pacific Cancer Supportive Care Drugs Market Outlook, By Lung Cancer (2017-2027) ($MN)
  • Table 89 Asia Pacific Cancer Supportive Care Drugs Market Outlook, By Leukemia (2017-2027) ($MN)
  • Table 90 Asia Pacific Cancer Supportive Care Drugs Market Outlook, By Ovarian Cancer (2017-2027) ($MN)
  • Table 91 Asia Pacific Cancer Supportive Care Drugs Market Outlook, By Breast Cancer (2017-2027) ($MN)
  • Table 92 Asia Pacific Cancer Supportive Care Drugs Market Outlook, By Melanoma (2017-2027) ($MN)
  • Table 93 Asia Pacific Cancer Supportive Care Drugs Market Outlook, By Bladder Cancer (2017-2027) ($MN)
  • Table 94 Asia Pacific Cancer Supportive Care Drugs Market Outlook, By Prostate Cancer (2017-2027) ($MN)
  • Table 95 Asia Pacific Cancer Supportive Care Drugs Market Outlook, By Drug Class (2017-2027) ($MN)
  • Table 96 Asia Pacific Cancer Supportive Care Drugs Market Outlook, By Nonsteroidal Anti-Inflammatory Drugs (NSAIDS) (2017-2027) ($MN)
  • Table 97 Asia Pacific Cancer Supportive Care Drugs Market Outlook, By Antiemetics (2017-2027) ($MN)
  • Table 98 Asia Pacific Cancer Supportive Care Drugs Market Outlook, By Erythropoietin-stimulating Agents (ESAS) (2017-2027) ($MN)
  • Table 99 Asia Pacific Cancer Supportive Care Drugs Market Outlook, By Bisphosphonates (2017-2027) ($MN)
  • Table 100 Asia Pacific Cancer Supportive Care Drugs Market Outlook, By Granulocyte-Colony Stimulating Factors (G-CSFS) (2017-2027) ($MN)
  • Table 101 Asia Pacific Cancer Supportive Care Drugs Market Outlook, By Opioids (2017-2027) ($MN)
  • Table 102 Asia Pacific Cancer Supportive Care Drugs Market Outlook, By Topical (2017-2027) ($MN)
  • Table 103 Asia Pacific Cancer Supportive Care Drugs Market Outlook, By Other Drug Classes (2017-2027) ($MN)
  • Table 104 Asia Pacific Cancer Supportive Care Drugs Market Outlook, By Neutropenia (2017-2027) ($MN)
  • Table 105 Asia Pacific Cancer Supportive Care Drugs Market Outlook, By Antineoplastic Antibiotics (2017-2027) ($MN)
  • Table 106 Asia Pacific Cancer Supportive Care Drugs Market Outlook, By Distribution Channel (2017-2027) ($MN)
  • Table 107 Asia Pacific Cancer Supportive Care Drugs Market Outlook, By Retail Pharmacies (2017-2027) ($MN)
  • Table 108 Asia Pacific Cancer Supportive Care Drugs Market Outlook, By Hospital Pharmacies (2017-2027) ($MN)
  • Table 109 Asia Pacific Cancer Supportive Care Drugs Market Outlook, By Online Pharmacies (2017-2027) ($MN)
  • Table 110 Asia Pacific Cancer Supportive Care Drugs Market Outlook, By Application (2017-2027) ($MN)
  • Table 111 Asia Pacific Cancer Supportive Care Drugs Market Outlook, By Radiation Therapy (2017-2027) ($MN)
  • Table 112 Asia Pacific Cancer Supportive Care Drugs Market Outlook, By Chemotherapy (2017-2027) ($MN)
  • Table 113 South America Cancer Supportive Care Drugs Market Outlook, By Country (2017-2027) ($MN)
  • Table 114 South America Cancer Supportive Care Drugs Market Outlook, By Cancer Type (2017-2027) ($MN)
  • Table 115 South America Cancer Supportive Care Drugs Market Outlook, By Liver Cancer (2017-2027) ($MN)
  • Table 116 South America Cancer Supportive Care Drugs Market Outlook, By Lung Cancer (2017-2027) ($MN)
  • Table 117 South America Cancer Supportive Care Drugs Market Outlook, By Leukemia (2017-2027) ($MN)
  • Table 118 South America Cancer Supportive Care Drugs Market Outlook, By Ovarian Cancer (2017-2027) ($MN)
  • Table 119 South America Cancer Supportive Care Drugs Market Outlook, By Breast Cancer (2017-2027) ($MN)
  • Table 120 South America Cancer Supportive Care Drugs Market Outlook, By Melanoma (2017-2027) ($MN)
  • Table 121 South America Cancer Supportive Care Drugs Market Outlook, By Bladder Cancer (2017-2027) ($MN)
  • Table 122 South America Cancer Supportive Care Drugs Market Outlook, By Prostate Cancer (2017-2027) ($MN)
  • Table 123 South America Cancer Supportive Care Drugs Market Outlook, By Drug Class (2017-2027) ($MN)
  • Table 124 South America Cancer Supportive Care Drugs Market Outlook, By Nonsteroidal Anti-Inflammatory Drugs (NSAIDS) (2017-2027) ($MN)
  • Table 125 South America Cancer Supportive Care Drugs Market Outlook, By Antiemetics (2017-2027) ($MN)
  • Table 126 South America Cancer Supportive Care Drugs Market Outlook, By Erythropoietin-stimulating Agents (ESAS) (2017-2027) ($MN)
  • Table 127 South America Cancer Supportive Care Drugs Market Outlook, By Bisphosphonates (2017-2027) ($MN)
  • Table 128 South America Cancer Supportive Care Drugs Market Outlook, By Granulocyte-Colony Stimulating Factors (G-CSFS) (2017-2027) ($MN)
  • Table 129 South America Cancer Supportive Care Drugs Market Outlook, By Opioids (2017-2027) ($MN)
  • Table 130 South America Cancer Supportive Care Drugs Market Outlook, By Topical (2017-2027) ($MN)
  • Table 131 South America Cancer Supportive Care Drugs Market Outlook, By Other Drug Classes (2017-2027) ($MN)
  • Table 132 South America Cancer Supportive Care Drugs Market Outlook, By Neutropenia (2017-2027) ($MN)
  • Table 133 South America Cancer Supportive Care Drugs Market Outlook, By Antineoplastic Antibiotics (2017-2027) ($MN)
  • Table 134 South America Cancer Supportive Care Drugs Market Outlook, By Distribution Channel (2017-2027) ($MN)
  • Table 135 South America Cancer Supportive Care Drugs Market Outlook, By Retail Pharmacies (2017-2027) ($MN)
  • Table 136 South America Cancer Supportive Care Drugs Market Outlook, By Hospital Pharmacies (2017-2027) ($MN)
  • Table 137 South America Cancer Supportive Care Drugs Market Outlook, By Online Pharmacies (2017-2027) ($MN)
  • Table 138 South America Cancer Supportive Care Drugs Market Outlook, By Application (2017-2027) ($MN)
  • Table 139 South America Cancer Supportive Care Drugs Market Outlook, By Radiation Therapy (2017-2027) ($MN)
  • Table 140 South America Cancer Supportive Care Drugs Market Outlook, By Chemotherapy (2017-2027) ($MN)
  • Table 141 Middle East & Africa Cancer Supportive Care Drugs Market Outlook, By Country (2017-2027) ($MN)
  • Table 142 Middle East & Africa Cancer Supportive Care Drugs Market Outlook, By Cancer Type (2017-2027) ($MN)
  • Table 143 Middle East & Africa Cancer Supportive Care Drugs Market Outlook, By Liver Cancer (2017-2027) ($MN)
  • Table 144 Middle East & Africa Cancer Supportive Care Drugs Market Outlook, By Lung Cancer (2017-2027) ($MN)
  • Table 145 Middle East & Africa Cancer Supportive Care Drugs Market Outlook, By Leukemia (2017-2027) ($MN)
  • Table 146 Middle East & Africa Cancer Supportive Care Drugs Market Outlook, By Ovarian Cancer (2017-2027) ($MN)
  • Table 147 Middle East & Africa Cancer Supportive Care Drugs Market Outlook, By Breast Cancer (2017-2027) ($MN)
  • Table 148 Middle East & Africa Cancer Supportive Care Drugs Market Outlook, By Melanoma (2017-2027) ($MN)
  • Table 149 Middle East & Africa Cancer Supportive Care Drugs Market Outlook, By Bladder Cancer (2017-2027) ($MN)
  • Table 150 Middle East & Africa Cancer Supportive Care Drugs Market Outlook, By Prostate Cancer (2017-2027) ($MN)
  • Table 151 Middle East & Africa Cancer Supportive Care Drugs Market Outlook, By Drug Class (2017-2027) ($MN)
  • Table 152 Middle East & Africa Cancer Supportive Care Drugs Market Outlook, By Nonsteroidal Anti-Inflammatory Drugs (NSAIDS) (2017-2027) ($MN)
  • Table 153 Middle East & Africa Cancer Supportive Care Drugs Market Outlook, By Antiemetics (2017-2027) ($MN)
  • Table 154 Middle East & Africa Cancer Supportive Care Drugs Market Outlook, By Erythropoietin-stimulating Agents (ESAS) (2017-2027) ($MN)
  • Table 155 Middle East & Africa Cancer Supportive Care Drugs Market Outlook, By Bisphosphonates (2017-2027) ($MN)
  • Table 156 Middle East & Africa Cancer Supportive Care Drugs Market Outlook, By Granulocyte-Colony Stimulating Factors (G-CSFS) (2017-2027) ($MN)
  • Table 157 Middle East & Africa Cancer Supportive Care Drugs Market Outlook, By Opioids (2017-2027) ($MN)
  • Table 158 Middle East & Africa Cancer Supportive Care Drugs Market Outlook, By Topical (2017-2027) ($MN)
  • Table 159 Middle East & Africa Cancer Supportive Care Drugs Market Outlook, By Other Drug Classes (2017-2027) ($MN)
  • Table 160 Middle East & Africa Cancer Supportive Care Drugs Market Outlook, By Neutropenia (2017-2027) ($MN)
  • Table 161 Middle East & Africa Cancer Supportive Care Drugs Market Outlook, By Antineoplastic Antibiotics (2017-2027) ($MN)
  • Table 162 Middle East & Africa Cancer Supportive Care Drugs Market Outlook, By Distribution Channel (2017-2027) ($MN)
  • Table 163 Middle East & Africa Cancer Supportive Care Drugs Market Outlook, By Retail Pharmacies (2017-2027) ($MN)
  • Table 164 Middle East & Africa Cancer Supportive Care Drugs Market Outlook, By Hospital Pharmacies (2017-2027) ($MN)
  • Table 165 Middle East & Africa Cancer Supportive Care Drugs Market Outlook, By Online Pharmacies (2017-2027) ($MN)
  • Table 166 Middle East & Africa Cancer Supportive Care Drugs Market Outlook, By Application (2017-2027) ($MN)
  • Table 167 Middle East & Africa Cancer Supportive Care Drugs Market Outlook, By Radiation Therapy (2017-2027) ($MN)
  • Table 168 Middle East & Africa Cancer Supportive Care Drugs Market Outlook, By Chemotherapy (2017-2027) ($MN)

According to Stratistics MRC, the Global Cancer Supportive Care Drugs Market is accounted for $21.10 billion in 2018 and is expected to reach $27.53 billion by 2027 growing at a CAGR of 3.0% during the forecast period. Some of the key factors propelling the market growth are increasing healthcare expenditure, availability of advancement treatment, and rising occurrence of cancers. However, stringent regulatory process is the restraining factor for the growth of the market.

Cancer supportive care drugs are the drugs used to moderate the harmful side effects of cancer treatment by protecting the affected cells or organs.

By drug class, the granulocyte-colony stimulating factors (G-CSFS) segment is expected to grow at a significant market share during the forecast period as it is widely adopted because of its ability to restore the functioning of bone marrow. On the basis of geography, North America is anticipated to hold considerable market share during the forecast period as the advanced healthcare systems of the major economies attract the key industry players.

Some of the key players in Cancer Supportive Care Drugs Market include Johnson & Johnson, Amgen, Novartis, Hoffmann La- Roche, Baxter International, Acacia Pharma, Teva Pharmaceuticals Industries, Apr Applied Pharma Science Research, Fagron Group, and Kyowa Hakko Kirin.

Cancer Types Covered:

  • Liver Cancer
  • Lung Cancer
  • Leukemia
  • Ovarian Cancer
  • Breast Cancer
  • Melanoma
  • Bladder Cancer
  • Prostate Cancer

Drug Classes Covered:

  • Nonsteroidal Anti-Inflammatory Drugs (NSAIDS)
  • Antiemetics
  • Erythropoietin-stimulating Agents (ESAS)
  • Bisphosphonates
  • Granulocyte-Colony Stimulating Factors (G-CSFS)
  • Opioids
  • Topical
  • Other Drug Classes

Distribution Channels Covered:

  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies

Applications Covered:

  • Radiation Therapy
  • Chemotherapy

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • Italy
    • UK
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2017, 2018, 2019, 2023 and 2027
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter's five forces analysis, SWOT analysis, etc.
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Cancer Supportive Care Drugs Market, By Cancer Type

  • 5.1 Introduction
  • 5.2 Liver Cancer
  • 5.3 Lung Cancer
  • 5.4 Leukemia
  • 5.5 Ovarian Cancer
  • 5.6 Breast Cancer
  • 5.7 Melanoma
  • 5.8 Bladder Cancer
  • 5.9 Prostate Cancer

6 Global Cancer Supportive Care Drugs Market, By Drug Class

  • 6.1 Introduction
  • 6.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDS)
  • 6.3 Antiemetics
  • 6.4 Erythropoietin-stimulating Agents (ESAS)
  • 6.5 Bisphosphonates
  • 6.6 Granulocyte-Colony Stimulating Factors (G-CSFS)
  • 6.7 Opioids
  • 6.8 Topical
  • 6.9 Other Drug Classes
    • 6.9.1 Neutropenia
    • 6.9.2 Antineoplastic Antibiotics

7 Global Cancer Supportive Care Drugs Market, By Distribution Channel

  • 7.1 Introduction
  • 7.2 Retail Pharmacies
  • 7.3 Hospital Pharmacies
  • 7.4 Online Pharmacies

8 Global Cancer Supportive Care Drugs Market, By Application

  • 8.1 Introduction
  • 8.2 Radiation Therapy
  • 8.3 Chemotherapy

9 Global Cancer Supportive Care Drugs Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Johnson & Johnson
  • 11.2 Amgen
  • 11.3 Novartis
  • 11.4 Hoffmann La- Roche
  • 11.5 Baxter International
  • 11.6 Acacia Pharma
  • 11.7 Teva Pharmaceuticals Industries
  • 11.8 Apr Applied Pharma Science Research
  • 11.9 Fagron Group
  • 11.10 Kyowa Hakko Kirin
Back to Top
전화 문의
F A Q